Stockreport

Structure Therapeutics Announces Participation in Upcoming Investor Conferences

Structure Therapeutics Inc.  (GPCR) 
PDF SAN FRANCISCO, Aug. 26, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clinical-stage global biopharmaceutical company developing novel oral sm [Read more]